Convergent Therapeutics

Next-Gen Targeted Radiotherapies

United States · $130.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$130.0M
Last Round
$40.0M Extension RoundAug 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Convergent Therapeutics is a biotechnology company developing next-generation targeted radiotherapies to treat cancer. It focuses on radioantibodies that deliver alpha-emitting payloads so radiation therapy is more targeted and effective, with short-range alpha particles that minimize exposure to neighboring healthy tissue. Linked to proprietary antibodies, these radioantibodies specifically target cancer cells and deliver the radioactive payload directly into the cell.

Summary

Convergent Therapeutics is a Biotech company based in United States. It has raised $130.0M in total across 2 rounds, most recently a $40.0M Extension Round in Aug 2024. Investors include Novo Holdings A/S, OrbiMed and RA Capital Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundAug 2024
$40.0M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Convergent Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/convergent-therapeutics"><img src="https://indexed.vc/api/badge/company/convergent-therapeutics" alt="Convergent Therapeutics on Indexed.vc" width="260" height="76" /></a>